The medical examination of the Suzhou Maritime Route Blue sea business: "There is gold in the feces"

Dark Horse contacts Many entrepreneurs in all kinds of Red Sea struggling, in fact, many people do not pay attention to the field, is a good opportunity to start a business. Suzhou Sea-Route Biotechnology Co., Ltd. (hereinafter referred to as SEA) is a supplier of automated stool analysis instruments and solutions. "By sea, it is a mission to protect and improve the working environment of health care workers and improve the well-being index of health care workers," the official said. "The tool that the sea uses to complete this mission is the automatic Stool analyzer that they develop independently." The most intuitive function of this set of instruments is that it replaces the traditional manual detection method. In accordance with the current routine procedures, laboratory doctors to take stool samples to be examined, at least need to stir, observation, smell and other steps, face a strong sense of the test. The idea of an automatic stool analyzer comes from the founder of the Sea, Lee Lung. The company is said to have applied for 24 domestic patents and 3 international patents, and is committed to becoming a leader in the industry. The system of Shandong Zaozhuang people Lee Lung, 49 years old this year. He was assigned to pediatrics at a hospital in Zaozhuang, Shandong Province, after graduating from the clinical medicine major of Jining Medical College in 1985. 1989, Li-Lung entered Nanjing Railway Medical College, majoring in Pediatrics, and he was working for a master's degree. He was a railroad worker who, in addition to bonuses, enjoyed all the benefits of a railroad worker. During the study, Lee Lung and Yang Yunchang, editor of the Journal of Clinical Examination, became a friend. Yang was also the director of pediatrics at the People's Hospital of Jiangsu province, and his interest in clinical testing affected Lee-lung. Testing without direct contact with the human body, doctors can play a lot of space, can try some new methods. "said Lee Lung. But the practice of pediatrics is to put safety first, and not to encourage the latest technology or the latest equipment. After graduation, Lee-Lung returned to Shandong, into the Jinan Railway Hospital Pediatrics. Pediatricians have to do a lot of stool samples every day, which is an important basis for diagnosing children's condition. The detection is done mainly by observing the feces color, character and smell. For smells, sour-smelling feces is mostly associated with indigestion, and if there is a foul odor in feces, the likelihood of bacterial infection is great. The Times are progressing, and young physicians are increasingly unable to accept traditional methods of testing, but few are trying to innovate. Not long after, Lee Lung decided to leave Pediatrics. He felt that pediatrics is very hard, work is tired, the treatment is low, the doctor patient dispute is many. Transfer department is not so easy, leaving job-hopping more difficult, by virtue of the relationship between the father, Lee-lung back to study before the Zaozhuang that hospital, serving the inspection section. Although the test is the interest of Lee, but the laboratory is not what he imagined, such as the general low quality of employees, the relationship between colleagues is also very complex. Later, the inspection section occurred to him a very objectionable thing: Zhang and Doe handover, Zhang to the patient did a blood type test, but four consecutive patients were measured out of O-type blood, Zhang feel like a little problem, a check found that the reagent failed. Before Zhang, Doe was in charge of the work. Check the wrong blood type belongs to the accident, the accountability, Dick shifting, both sides diverging. See this scene, as two colleagues of Lee Dragon, feel very sad, he does not want to continue to stay in this place. Products at this time, a pharmaceutical company in Shanghai found Lee Dragon, asked him to be responsible for the rapid quantitative detection of C-reactive protein clinical promotion. C-reactive protein can accurately determine whether the patient's fever is caused by viral infection or bacterial infection. Lee Dragon thought it was very valuable, so decisively joined the company. Nearly 70% of pediatric patients are accompanied by a certain degree of fever. "he said. It was 1999, and his monthly salary was abruptly raised to the million-dollar level. Join the company soon, go to a hospital to do drug promotion, Lee Dragon found a phenomenon: the hospital clearly to his introduction of the products are very interested, but never mention procurement. It's strange that they don't seem to need to buy a good thing, even if it helps the clinic and the whole hospital. "Later he realized that he had not put business" on the other side of the matter to explain clearly. Later, he learned to solve business problems through the familiar agents of the hospital. This experience let Lee Dragon accumulated a lot of contacts, including distributors, pharmaceutical companies and so on. In 2005, under the encouragement of friends, he resigned his business--and four other friends, invested 5 million yuan, set up a biochemical reagent production enterprise. The threshold of reagents is very low, mainly imitate the products of foreign companies, and the market is very good. "said Lee. Later, the other partners withdrew, Li Quanpan took over the company. He's been watching the stool test. Until 2007, the hospital was still using hand-tested stool samples. Some big hospitals, the daily stool detection is very large, but the efficiency is very low, the working environment is very bad. Manual testing has been quite unaffected by the inspectors, and even if it takes 10 yuan to complete the bowel cancer stool test, popularization is not progressing well. Lee Dragon began to have the idea of making a fully automatic stool analyzer. Because of previous experience, Lee Dragon's first generation of fecal analysis equipment developed in 2009, Shanghai Gishon Biological Technology Co., Ltd. was founded. But the clinical effect of this instrument is not satisfactory. For example, it has a limited number of samples per processing, up to 10. In addition, feces can easily plug the instrument to death, does not work properly. 2010, Lee Dragon burn His bridges, sold his biochemical reagents company, fully developed automatic Stool analyzer, a total of more than 10 million yuan, of which the light patent applications spent 1/3. 2011, the new venture investment decided to invest Gishongshen. At that time, Lee Lung has moved the company to Suzhou, renamed Suzhou Sea Biotechnology Co., Ltd. At the end of the signing, Lee decided not to invest money, because he did not want to be constrained by capital, so that can not calm down to do things. In the future development of the second generation of instruments, Lee Dragon invited a group in the stool analysis, medical machinery, software design and other experienced professionals to discuss, and carried out a number of experiments and improvements, including the expansion of specimens, equipped with special high-resolution microscopicMirror, high pixel camera and so on. After the improvement of the complete set of testing equipment, by the Analyzer mainframe, computer, two monitors, printer composition. Its basic work flow is a mechanical arm plus thinner, and the other arm to the counting pool, and the reagent sample. All the detection data is generated by the host and exported to the computer, the results are printed and the test is completed. All operations are controlled by the computer and the Doctor is isolated from the specimen. Lee Lung does not think the equipment is sophisticated in technology: medical equipment, safety first, usually not use the most cutting-edge technology. And I do, is an integrated nature of the work, gathered a group of people, the integration of a group of technology, with simple, economic technical means to solve the problem. "It is said that the sea-line of the latest instrument, can be achieved hourly test 800 samples, continuous sampling, continuous addition of reagents, can be detected at the same time stool routine, gastrointestinal tumor markers, Helicobacter pylori, diarrhea pathogens, intestinal viruses, parasites and so on." Such an instrument, sold to the hospital price is more than 300,000 yuan. Lee said, with the help of the previous accumulation of dealer resources, his products in marketing is not too difficult, as early as the end of 2010, he began to have income. According to the figures provided by Lee, up to now, there are more than 100 hospitals in the country have been using his equipment. In addition to the equipment itself, the sea route also supplies the relevant testing reagents--by the cooperative factory. So far, the total revenue after the operation of the sea is close to 30 million yuan (2013 revenue of 10 million yuan), of which equipment sales accounted for 60%, reagents for 40%. Slightly profitable. Lee Dragon hope that the future of reagent sales accounted for up to 80%. The reagent's gross margin is higher than the instrument, can reach 70%, and the future demand will be more and more big. "At present, the sea is starting to establish its own reagent processing plant." In addition to public hospitals, Lee Lung also aimed at third-party testing agencies, private hospitals, medical centers and insurance companies. According to Lee Dragon, the Sea has been with a number of listed companies, chain agencies have reached a cooperative intention, if realized, any cooperative company, can bring more than 100 million yuan of annual revenue. Lee Dragon believes that this industry, the future domestic market size can be as high as 8 billion yuan, by then, the sea is expected to get more than 30% of the market share. Xu Lijun, "entrepreneur" reporter